Prestige Consumer Healthcare (PBH) vs Schrodinger (SDGR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Schrodinger (SDGR) has outperformed Prestige Consumer Healthcare (PBH) over the past year, gaining 35.4% versus a loss of 24.3%. Over five years, PBH leads with a -18.6% price change compared with -50.7% for SDGR. Prestige Consumer Healthcare is the larger company by market cap ($2.25 billion vs $2.04 billion), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PBH | SDGR |
|---|---|---|
| Share price | $47.57 | $27.29 |
| Market cap | $2.25B | $2.04B |
| 1-day change | +2.43% | -5.57% |
| YTD return | -22.89% | +52.63% |
| 1-year return | -24.34% | +35.37% |
| 5-year return | -18.57% | -50.70% |
| P/E ratio (TTM) | 13.00 | — |
| Forward P/E | 9.36 | — |
| EPS (TTM) | $3.66 | $-0.74 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $71.07 | $33.78 |
| 52-week low | $42.62 | $10.95 |
| Distance from 52-week high | -33.07% | -19.21% |
| Analyst consensus | buy | none |
| Avg. price target upside | +42.53% | -21.47% |
| Average volume | 545.74K | 1.69M |
| Shares outstanding | 47.37M | 65.64M |
| Employees | 890 | 850 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SDGR has outperformed PBH by 59.7 percentage points over the past year.
About Prestige Consumer Healthcare
PBH stock →Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare.
Health Care · Biotechnology: Pharmaceutical Preparations · 890 employees
About Schrodinger
SDGR stock →Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery.
Health Care · Biotechnology: Pharmaceutical Preparations · 850 employees
PBH vs SDGR FAQ
Which is bigger, Prestige Consumer Healthcare or Schrodinger?
Prestige Consumer Healthcare (PBH) is larger, with a market capitalization of $2.25B compared with $2.04B for Schrodinger (SDGR).
Which stock has performed better over the past year, PBH or SDGR?
SDGR returned +35.37% over the past 12 months, compared with -24.34% for PBH (price return, excluding dividends). Past performance does not predict future results.
Are Prestige Consumer Healthcare and Schrodinger in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.